Prostate cancer Cancer Malignant neoplasm of prostate
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Men 2. Have locally contined prostate cancer up to stage T3BNO 3. Have received neoadjuvant hormonal therapy 4. Have completed radiotherapy three to four months prior to the intervention 5. Have urinary syptopms and an IPSS score of 8+ 6. Have sufficient understanding of written and spoken English Added 27/01/2014: 7. Brachytherapy patients
Exclusion criteria
Exclusion criteria: 1. Have a urinary tract infection 2. Have a current psychiatric referral 3. Have a current referral for memory issues 4. Require an interpreter
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary syptoms measured by the International Prostate Symptom Score (IPSS); Timepoint(s): At two months (end of intervention) and 6 months past baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life measured by the EORTC 25, and emotional distress measured by the EORTC 30 ? both at 2 and 6 months post baseline. | — |
Countries
England, United Kingdom